THE REGULATION OF AORTIC ENDOTHELIAL-CELLS BY PURINES AND PYRIMIDINES INVOLVES COEXISTING P2Y-PURINOCEPTORS AND NUCLEOTIDE RECEPTORS LINKED TO PHOSPHOLIPASE-C

被引:81
作者
WILKINSON, GF [1 ]
PURKISS, JR [1 ]
BOARDER, MR [1 ]
机构
[1] UNIV LEICESTER,DEPT PHARMACOL & THERAPEUT,POB 138,MED SCI BLDG,UNIV RD,LEICESTER LE1 9HN,ENGLAND
基金
英国惠康基金;
关键词
ENDOTHELIAL CELLS; P-2-PURINOCEPTORS; P2Y; NUCLEOTIDE RECEPTORS;
D O I
10.1111/j.1476-5381.1993.tb12862.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We have examined the phospholipase C responses in bovine aortic endothelial cells to purines (ATP, ADP and analogues) and the pyrimidine, uridine triphosphate (UTP). 2 The cells responded to purines in a manner consistent with the presence of P2y purinoceptors; both 2-methylthioadenosine 5'-triphosphate (2MeSATP) and adenosine 5'-0-(2-thiodiphosphate) (ADPbetaS) were potent agonists (EC50 0.41 mum and 0.85 mum respectively) while beta, gamma-methylene ATP at 300 mum was not. 3 The cells also responded to UTP. The maximal response to UTP was less than that for either 2MeSATP and ADPbetaS while adenosine 5'-0-(3-thiotriphosphate) (ATPgammaS) gave the largest maximal response. 4 The concentration-effect curve to UTP was additive in the presence of either 2MeSATP or ADPbetaS. However, the concentration-effect curves to ATPgammaS reached the same maximum in the presence or absence of UTP. 5 Suramin, at concentrations between 10 mum and 100 mum was a competitive antagonist for the response to ADPbetaS and 2MeSATP but not the response to UTP. 6 The results show that there are two separate, co-existing, receptor populations: P2y-purinoceptors (responding to purines) and nucleotide receptors (responding to both purines and pyrimidines). We conclude that purines such as ATP/ADP may regulate aortic endothelial cells by interacting with two phospholipase C-linked receptors.
引用
收藏
页码:689 / 693
页数:5
相关论文
共 23 条
[1]  
ALLSUP DJ, 1990, MOL PHARMACOL, V38, P84
[2]   CULTURE OF ARTERIAL ENDOTHELIAL CELLS - CHARACTERIZATION AND GROWTH OF BOVINE AORTIC CELLS [J].
BOOYSE, FM ;
SEDLAK, BJ ;
RAFELSON, ME .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1975, 34 (03) :825-839
[3]  
BROWN HA, 1991, MOL PHARMACOL, V40, P648
[4]   IS THERE A BASIS FOR DISTINGUISHING 2 TYPES OF P2-PURINOCEPTOR [J].
BURNSTOCK, G ;
KENNEDY, C .
GENERAL PHARMACOLOGY, 1985, 16 (05) :433-440
[5]   A NOVEL EXTRACELLULAR NUCLEOTIDE RECEPTOR COUPLED TO PHOSPHOINOSITIDASE-C IN PITUITARY-CELLS [J].
DAVIDSON, JS ;
WAKEFIELD, IK ;
SOHNIUS, U ;
VANDERMERWE, PA ;
MILLAR, RP .
ENDOCRINOLOGY, 1990, 126 (01) :80-87
[6]   STIMULATION OF PROSTACYCLIN RELEASE FROM AORTIC SMOOTH-MUSCLE CELLS BY PURINE AND PYRIMIDINE NUCLEOTIDES [J].
DEMOLLE, D ;
LAGNEAU, C ;
BOEYNAEMS, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (03) :339-343
[7]   EXTRACELLULAR NUCLEOTIDES STIMULATE RECEPTOR-MEDIATED CALCIUM MOBILIZATION AND INOSITOL PHOSPHATE PRODUCTION IN HUMAN-FIBROBLASTS [J].
FINE, J ;
COLE, P ;
DAVIDSON, JS .
BIOCHEMICAL JOURNAL, 1989, 263 (02) :371-376
[8]   EXTRACELLULAR ATP - EFFECTS, SOURCES AND FATE [J].
GORDON, JL .
BIOCHEMICAL JOURNAL, 1986, 233 (02) :309-319
[9]  
HOUSTON DA, 1987, J PHARMACOL EXP THER, V241, P501
[10]   SURAMIN ANTAGONIZES RESPONSES TO P2-PURINOCEPTOR AGONISTS AND PURINERGIC NERVE-STIMULATION IN THE GUINEA-PIG URINARY-BLADDER AND TAENIA-COLI [J].
HOYLE, CHV ;
KNIGHT, GE ;
BURNSTOCK, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (03) :617-621